A carregar...
Sorafenib prevents the proliferation and induces the apoptosis of liver cancer cells by regulating autophagy and hypoxia-inducible factor-1
Sorafenib has been approved as a systemic drug for advanced liver cancer; however, the underlying mechanisms remain unclear. The present study aimed to investigate the effects of sorafenib on the proliferation, autophagy and apoptosis of HepG2 cells under hypoxia. Briefly, reverse transcription-quan...
Na minha lista:
| Publicado no: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8311259/ https://ncbi.nlm.nih.gov/pubmed/34345262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.10412 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|